secwatch.observer — SEC 8-K summary
======================================

Issuer:     JOINT Corp (JYNT)
CIK:        0001612630
Form:       8-K
Filed at:   2023-11-09T23:59:59+00:00
Accession:  0001171843-23-006953
Event type: earnings
Sentiment:  negative
Materiality: 0.78
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Joint Corp Q3 net loss $716K; plans to refranchise majority of corporate clinics
--------------------------------------------------------------------------------

- Revenue $29.5M (+11% YoY); net loss $0.05/sh vs income $0.05/sh in Q3 2022.
- Operating loss $898K vs operating income $732K; Adj EBITDA $2.9M vs $3.1M.
- System-wide sales +8% to $119.3M; comp sales flat; total clinics 914.
- Board authorized plan to refranchise/sell majority of corporate-owned clinics.
- Reaffirmed FY 2023 guidance: revenue $115-118M, Adj EBITDA $11-12.5M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1612630/000117184323006953/0001171843-23-006953-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1612630/000117184323006953/f8k_091123.htm
  HTML page:      https://secwatch.observer/filing/0001171843-23-006953

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer